PubMed 37249896

PubMed ID: 37249896

View on PubMed
Eliciting Targeted Mutations in Medicago sativa Using CRISPR/Cas9-Mediated Genome Editing: A Potential Tool for the Improvement of Disease Resistance.
Authors: Subedi Udaya, Burton Hughes Kimberley, Chen Guanqun, Hannoufa Abdelali, Singer Stacy D
Journal: Methods in molecular biology (Clifton, N.J.) (Methods Mol Biol), Vol.2659(), 2023

DOI: 10.1134/S0026893320010069 PMCID: 6352712

Abstract
CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) has become a breeding tool of choice for eliciting targeted genetic alterations in crop species as a means of improving a wide range of agronomic traits, including disease resistance, in recent years. With the recent development of CRISPR/Cas9 technology in Medicago sativa (alfalfa), which is an important perennial forage legume grown worldwide, its use for the enhancement of pathogen resistance is almost certainly on the horizon. In this chapter, we present detailed procedures for the generation of a single nonhomologous end-joining-derived indel at a precise genomic locus of alfalfa via CRISPR/Cas9. This method encompasses crucial steps in this process, including guide RNA design, binary CRISPR vector construction, Agrobacterium-mediated transformation of alfalfa explants, and molecular assessments of transformed genotypes for transgene and edit identification.
Publication Types
Journal Article
Keywords
Alfalfa CRISPR/Cas Guide RNAs Non-homologous end-joining Targeted mutations
Related Articles